Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101318146A reveals a novel organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Novel phase-transfer catalyst method for Ivabradine synthesis. Reduces reaction time, improves purity, avoids chromatography. Reliable supply chain partner for commercial scale.
Patent CN111411095B discloses a novel recombinant (R)-ω-transaminase mutant with high activity and stereoselectivity for efficient sitagliptin intermediate production, ensuring supply chain stability.
Novel composite catalyst method reduces time and cost for Ivabradine manufacturing ensuring high purity and supply chain reliability for global partners.
Patent CN112094856B discloses high-efficiency transaminase mutants for sitagliptin synthesis, achieving >99.95% e.e. and enabling significant cost reduction in API manufacturing.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Patent CN110981919A details a one-pot C-H activation route for eight-membered palladacycles, offering significant cost reduction in organometallic catalyst manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Patent CN108675942A reveals nanometer vanadium iron catalyst for aromatic nitriles. Mild conditions, high yield, cost reduction in pharmaceutical intermediates manufacturing.
Novel Grignard-based synthesis of L-nicotine offers cost reduction and scalability. Reliable supplier for pharmaceutical and agrochemical intermediates with stringent QC.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Patent CN1837168A details a novel SnCl4-catalyzed synthesis of 1,3,5-triphenylbenzene, offering high purity for OLED materials and significant cost reduction in electronic chemical manufacturing.
Patent CN103214534A details improved cordycepin synthesis ensuring high purity and yield for reliable pharmaceutical intermediates supplier cost reduction.
Patent CN102516139A details a green synthesis of phenylene sulfides using ionic liquids and solid superacids, offering high purity and cost reduction in fine chemical manufacturing.
Patent CN112375012B reveals safer liquid cyanide route for fipronil intermediate. Enhances supply chain reliability and reduces solvent recovery costs significantly.
Novel palladium-catalyzed route for fluoroalkyl substituted pyrrole indoles offers mild conditions and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Patent CN1166628C reveals a novel AlCl3-ZnCl2 catalytic route for N,N-dicyanoethyl arylamine, offering higher yields and lower energy consumption for dye manufacturers.
Novel synthetic route for glibenclamide improves purity and yield. Reduces impurities via protective groups and phase transfer catalysis for reliable supply.
Patent CN114890999B reveals a 5-step PQQ synthesis with 39% yield. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.